This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scheithe, R. Articles by Hrboticky, N. Search for Related Content PubMed PubMed Citation Articles by Scheithe, R. Articles by Hrboticky, N. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1024-1031.)
© 1997 American Heart Association, Inc.

Articles

Acetylated LDL Endocytosis by the Human Monocytic Mono Mac 6sr Cells Is Not Mediated by the Macrophage Type I and II Scavenger Receptors

Rupert Scheithe; Anne K. Heidenthal; Ulrich Danesch; Eva Mauthner; Gerhard Hapfelmeier; Alexander Becker; Angelika Pietsch; Peter C. Weber; ; Nina Hrboticky

From the Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Ludwig-Maximilians-Universität, Pettenkoferstr 9, 80336 Munich, Germany.

Correspondence to N. Hrboticky, Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Pettenkoferstr 9, 80336 Munich, Germany.

Abstract We recently reported that the human monocytic Mono Mac 6sr cell line constitutively takes up and degrades acetylated (acLDL) and oxidized LDL through receptor-specific pathways. The present studies were undertaken to further characterize the acLDL binding site on a functional and molecular basis. The degradation of acLDL increased during differentiation of Mono Mac 6sr cells with lipopolysaccharide (10 ng/mL, 72 hours) and low concentrations of phorbol 12-myristate 13-acetate (PMA; 0.1 to 1.0 ng/mL, 72 hours). Higher doses of PMA (5 or 10 ng/mL), however, decreased acLDL degradation. Scatchard plots of acLDL binding in untreated and LPS-differentiated Mono Mac 6sr cells were nonlinear and suggested the presence of more than one binding site. Although the ligand specificity of the acLDL receptor in Mono Mac 6sr cells resembles that of the macrophage type I and type II scavenger receptors, we did not detect mRNA of either receptor type in untreated or differentiated Mono Mac 6sr cells by means of Northern blotting and reverse transcription polymerase chain reaction. Furthermore, ligand blotting with ¹²⁵I-acLDL failed to detect the 220-kD types I and II scavenger receptor protein. Thus, Mono Mac 6sr cells express an acLDL receptor that is distinct from the type I and type II scavenger receptor found in human monocyte–derived macrophages but that, like the latter, is induced during monocytic differentiation.

Key Words: acLDL • Mono Mac 6 cells • scavenger receptor • monocyte differentiation • atherosclerosis

This article has been cited by other articles:

				A. Rodriguez, P. S. Bachorik, and S.-B. Wee Novel Effects of the Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibitor 58-035 on Foam Cell Development in Primary Human Monocyte–Derived Macrophages Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2199 - 2206. [Abstract] [Full Text] [PDF]

				G. Draude, P. von Hundelshausen, M. Frankenberger, H. W. L. Ziegler-Heitbrock, and C. Weber Distinct scavenger receptor expression and function in the human CD14+/CD16+ monocyte subset Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1144 - H1149. [Abstract] [Full Text] [PDF]